I bought some more today (prior to the US market open in Germany) for an equivalent of 9.5 USc/share. Just checked again after a couple of hours and am positively surprised to be 30% in the money (at least on this last purchase).
Good things are heading our way, I am sure.
@Buildit,my guess is that the reason for this increase is the general uptrend of Biotechs in the vaccine business die to the new omikron variant of the virus.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links